Document is current
Any future updates will be listed below
-
Authors
Thanasukarn, Vasin
Srisuk, Tharatip
Luvira, Vor
Tipwaratorn, Theerawee
Jareanrat, Apiwat
Rattanarak, Krit
Kraphunpongsakul, Khanisara
Khuntikeo, Natcha
Chindaprasirt, Jarin
Sanlung, Thanachai
Chamadol, Nittaya
Koonmee, Supinda
Sa-Ngiamwibool, Prakasit
Klanrit, Poramate
Wangwiwatsin, Arporn
Namwat, Nisana
Loilome, Watcharin
Muangritdech, Nattha
Prajumwongs, Piya
Watanabe, Nobuyuki
Ebata, Tomoki
Titapun, Attapol
-
Funding
Funding for this research was provided by:
the National Research Council of Thailand (NRCT) through the Thailand Grand Challenge: Fluke Free Thailand project and the Hub of Knowledge of Cholangiocarcinoma
- License Information
-
More Information
Article History
Received: 5 September 2024
Accepted: 22 October 2024
First Online: 31 October 2024
Declarations
:
: This study adhered to the principles of Good Clinical Practice, the Declaration of Helsinki, and relevant national regulations governing clinical studies. Informed consent was obtained from all participants, and the study protocol was approved by the Khon Kaen University Ethics Committee for Human Research under reference number HE671317. Clinical data and medical records were anonymized, with participants being identified only by hospital number (HN), ensuring that no individual could be personally identified.
: Not applicable.
: The authors declare no competing interests.
